AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
349 hedge funds and large institutions have $4.17B invested in Amedisys in 2021 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 120 increasing their positions, 122 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
349
Holders Change
-24
Holders Change %
-6.43%
% of All Funds
6.13%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
59
Increased
120
Reduced
122
Closed
80
Calls
$35.1M
Puts
$51.4M
Net Calls
-$16.3M
Net Calls Change
+$9.7M
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$67M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$58.1M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$48.4M |
| 4 |
D.E. Shaw & Co
New York
|
+$40.6M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$36.1M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$121M |
| 2 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
-$70.9M |
| 3 |
JPMorgan Chase & Co
New York
|
-$66.1M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$58.6M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$52.3M |
